159891 医疗
已收盘 04-24 15:00:00
资讯
新帖
简况
IPO动态：核心医疗拟在上交所科创板上市募资12.17亿元
证券之星 · 18:19
IPO动态：核心医疗拟在上交所科创板上市募资12.17亿元
医渡科技（02158）3-4倍PE背后的AI医疗价值重估新叙事
智通财经 · 15:39
医渡科技（02158）3-4倍PE背后的AI医疗价值重估新叙事
天星医疗(01609)4月24日-4月29日招股 拟全球发售842.185万股H股
智通财经 · 06:13
天星医疗(01609)4月24日-4月29日招股 拟全球发售842.185万股H股
楚天科技：楚天净邦目前以医疗洁净业务为主
证券之星 · 04-23 16:21
楚天科技：楚天净邦目前以医疗洁净业务为主
麦迪卫康（2159.HK）：一个被忽视的AI医疗“隐形冠军”
格隆汇 · 04-23 08:52
麦迪卫康（2159.HK）：一个被忽视的AI医疗“隐形冠军”
美中嘉和(02453)与妙佑医疗国际签署新合作协议 合作范围拓展至全生命周期健康服务领域
智通财经 · 04-22 22:27
美中嘉和(02453)与妙佑医疗国际签署新合作协议 合作范围拓展至全生命周期健康服务领域
郑磊2026年一季度表现，汇添富医疗积极成长一年持有混合A基金季度涨幅3.05%
证券之星 · 04-22 17:58
郑磊2026年一季度表现，汇添富医疗积极成长一年持有混合A基金季度涨幅3.05%
华康医疗：中标1.06亿元下一代异构集成先进封装技术及DDIC项目工程总承包
证券之星 · 04-22 17:00
华康医疗：中标1.06亿元下一代异构集成先进封装技术及DDIC项目工程总承包
GE医疗北京基地启动首条“黑灯”产线，关键零部件实现无人化作业
第一财经 · 04-22 16:47
GE医疗北京基地启动首条“黑灯”产线，关键零部件实现无人化作业
美股医疗 REITs 融资遇冷：National Healthcare(NHP.US)折价完成 IPO，最终募资4.62亿美元
智通财经 · 04-22 14:35
美股医疗 REITs 融资遇冷：National Healthcare(NHP.US)折价完成 IPO，最终募资4.62亿美元
商汤医疗宣布完成超5亿融资：估值10亿美元
雷递网 · 04-21
商汤医疗宣布完成超5亿融资：估值10亿美元
港股异动 | 微创机器人-B(02252)涨超3% 海外市场新增订单增速加快 公司深耕欧洲核心高端医疗重地
智通财经网 · 04-21
港股异动 | 微创机器人-B(02252)涨超3% 海外市场新增订单增速加快 公司深耕欧洲核心高端医疗重地
医渡科技(02158)盈利预喜：AI医疗迎来“成人礼”，千亿市值之路的底层逻辑已清晰
智通财经 · 04-21
医渡科技(02158)盈利预喜：AI医疗迎来“成人礼”，千亿市值之路的底层逻辑已清晰
阿波罗全球管理(APO)拟12.5亿美元收购麦克森(MCK)医疗外科解决方案部门约13%股权
金吾财讯 · 04-20
阿波罗全球管理(APO)拟12.5亿美元收购麦克森(MCK)医疗外科解决方案部门约13%股权
4月20日康辰药业跌5.59%，汇添富医疗积极成长一年持有混合A基金重仓该股
证券之星 · 04-20
4月20日康辰药业跌5.59%，汇添富医疗积极成长一年持有混合A基金重仓该股
艾柯医疗科创板IPO已问询 专注于神经介入创新医疗器械领域
智通财经 · 04-20
艾柯医疗科创板IPO已问询 专注于神经介入创新医疗器械领域
北京微仙医疗：因隔离控制不严致混装风险，召回部分颅内支架系统
蓝鲸财经 · 04-20
北京微仙医疗：因隔离控制不严致混装风险，召回部分颅内支架系统
20位巴西顶尖医院院长访华 中国高端医疗赋能拉美医疗升级
21世纪经济报道 · 04-20
20位巴西顶尖医院院长访华 中国高端医疗赋能拉美医疗升级
国盛证券：宠物医疗行业连锁化扩张 精品专科医院谋增长
智通财经 · 04-20
国盛证券：宠物医疗行业连锁化扩张 精品专科医院谋增长
招银国际：医疗板块风险偏好有温和的修复 推荐翰森制药(03692)等6股
智通财经 · 04-20
招银国际：医疗板块风险偏好有温和的修复 推荐翰森制药(03692)等6股
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159891","market":"SZ","secType":"STK","nameCN":"医疗","latestPrice":0.426,"timestamp":1777014216000,"preClose":0.428,"halted":0,"volume":15374604,"delay":0,"changeRate":-0.0047,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.002,"latestTime":"04-24 15:00:00","open":0.427,"high":0.43,"low":0.425,"amount":6575500,"amplitude":0.0117,"askPrice":0.426,"askSize":332,"bidPrice":0.425,"bidSize":2514,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":5,"adr":0,"adjPreClose":0.428,"symbolType":"fund","openAndCloseTimeList":[[1776994200000,1777001400000],[1777006800000,1777014000000]],"highLimit":0.471,"lowLimit":0.385,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":-0.085247,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/159891/wiki","defaultTab":"wiki","newsList":[{"id":"2629108278","title":"IPO动态：核心医疗拟在上交所科创板上市募资12.17亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629108278","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629108278?lang=zh_cn&edition=full","pubTime":"2026-04-24 18:19","pubTimestamp":1777025958,"startTime":"0","endTime":"0","summary":"证券之星消息，深圳核心医疗科技股份有限公司拟在上交所科创板上市，募资总金额为12.17亿元，保荐机构为华泰联合证券有限责任公司。从目前公布的财报来看，核心医疗2025年总资产为8.4亿元，净资产为7.52亿元；近3年净利润分别为nan元，-1.32亿元，-1.7亿元。从申请上市地看，上交所科创板过往一年接申请86家，申请成功36家，1家终止，其余尚在流程中。目前交易所已受理该申请，对核心医疗有兴趣的投资者可保持关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400055162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629813237","title":"医渡科技（02158）3-4倍PE背后的AI医疗价值重估新叙事","url":"https://stock-news.laohu8.com/highlight/detail?id=2629813237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629813237?lang=zh_cn&edition=full","pubTime":"2026-04-24 15:39","pubTimestamp":1777016366,"startTime":"0","endTime":"0","summary":"截止4月24日15时，在AI医疗龙头医渡科技当日十大买入经纪商中，外资占了七强，其中前六强均被处交资所垄断，引中JP摩根和摩根士丹利净买入超过50万股。这只是外资在医渡科技于4月20日发布盈喜公告后的一个缩影。2026财年上半年，医渡科技净亏损为1576万元，这意味着仅下半年，公司就实现了7076万元至8576万元的惊人盈利。从“烧钱”到“造血”，医渡科技用一份盈喜答卷，宣告了AI医疗商业化元年的到来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433309.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","AIPO","AGIX","BK1518","159891","ARTY","02158","BK1189","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629019869","title":"天星医疗(01609)4月24日-4月29日招股 拟全球发售842.185万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629019869","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629019869?lang=zh_cn&edition=full","pubTime":"2026-04-24 06:13","pubTimestamp":1776982424,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天星医疗(01609)于2026年4月24日-4月29日招股，拟全球发售842.185万股H股，香港公开发售占10%，国际发售占90%。每股发售股份98.50港元，每手50股，预期股份将于2026年5月5日(星期二)上午九时正开始在联交所买卖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433099.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629588686","title":"楚天科技：楚天净邦目前以医疗洁净业务为主","url":"https://stock-news.laohu8.com/highlight/detail?id=2629588686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629588686?lang=zh_cn&edition=full","pubTime":"2026-04-23 16:21","pubTimestamp":1776932477,"startTime":"0","endTime":"0","summary":"证券之星消息，楚天科技04月23日在投资者关系平台上答复投资者关心的问题。楚天净邦目前以医疗洁净业务为主，相邻行业拓展将根据业务实际情况规划、实施。感谢您的意见和建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300044470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0061","300358","159891","BK0077","BK0028","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629072233","title":"麦迪卫康（2159.HK）：一个被忽视的AI医疗“隐形冠军”","url":"https://stock-news.laohu8.com/highlight/detail?id=2629072233","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629072233?lang=zh_cn&edition=full","pubTime":"2026-04-23 08:52","pubTimestamp":1776905560,"startTime":"0","endTime":"0","summary":"麦迪卫康正在上演的，是一场脱胎换骨的身份革命。","market":"hk","thumbnail":"https://img2.gelonghui.com/93bcb-bade237a-176e-464a-b184-7dde59f996ee.jpg?guru_height=853&guru_width=1280&guru_size=135221","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/93bcb-bade237a-176e-464a-b184-7dde59f996ee.jpg?guru_height=853&guru_width=1280&guru_size=135221"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4512678","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["AIPO","BK1219","159891","02159","ARTY","AGIX","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629604093","title":"美中嘉和(02453)与妙佑医疗国际签署新合作协议 合作范围拓展至全生命周期健康服务领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2629604093","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629604093?lang=zh_cn&edition=full","pubTime":"2026-04-22 22:27","pubTimestamp":1776868078,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美中嘉和 发布公告，近期，公司与妙佑医学教育和研究基金会正式签署新合作协议，据此，公司于妙佑医疗国际的合作范围将从肿瘤诊疗的国际化、标准化，进一步拓展至涵盖疾病预防、筛查、康复及长期健康管理的全生命周期健康服务领域。妙佑医疗国际将以远程规划、辅导、现场评估及持续优化等方式，向公司导入其健康管理服务体系、运营标准及临床经验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159891","BK1209","02453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629014744","title":"郑磊2026年一季度表现，汇添富医疗积极成长一年持有混合A基金季度涨幅3.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629014744","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629014744?lang=zh_cn&edition=full","pubTime":"2026-04-22 17:58","pubTimestamp":1776851895,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2026年一季度末，基金经理郑磊旗下共管理7只基金，本季度表现最佳的为汇添富医疗积极成长一年持有混合A，季度净值涨3.05%。持有期间的估算收益率为317.89%，持有期间山东药玻在2018年到2020年的年报归属净利润增幅达57.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200041769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629016295","title":"华康医疗：中标1.06亿元下一代异构集成先进封装技术及DDIC项目工程总承包","url":"https://stock-news.laohu8.com/highlight/detail?id=2629016295","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629016295?lang=zh_cn&edition=full","pubTime":"2026-04-22 17:00","pubTimestamp":1776848400,"startTime":"0","endTime":"0","summary":"华康医疗(301235.SZ)公告称，公司与中国电子工程设计院股份有限公司组成的联合体，近日收到越润集成电路(绍兴)有限公司发出的《中标通知书》，确认联合体为“下一代异构集成先进封装技术及DDIC项目工程总承包”项目的中标供应商，中标范围主要涵盖A1厂房的洁净室装修及配套动力设施安装等。该项目中标价为1.06亿元，公司作为联合体牵头人，预计份额约为1.05亿元，占公司2024年度经审计营业收入的6.14%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200038751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629955016","title":"GE医疗北京基地启动首条“黑灯”产线，关键零部件实现无人化作业","url":"https://stock-news.laohu8.com/highlight/detail?id=2629955016","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629955016?lang=zh_cn&edition=full","pubTime":"2026-04-22 16:47","pubTimestamp":1776847620,"startTime":"0","endTime":"0","summary":"4月21日，GE医疗在北京基地成立35周年活动上宣布首条“黑灯”产线投入使用，实现CT探测器等关键零部件的“无人化作业”，大幅提升生产效率。截至目前，GE医疗北京基地已经交付了3.5万台/套探测器，并建立起中国产业链上下游供应商生态。GE医疗北京智造基地总经理冯健在接受记者采访时表示，GE医疗北京基地正在承担更多高精尖、关键零部件的生产，该基地生产的CT设备60%以上都发往全球市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-04-22/doc-inhvkixy5564059.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-22/doc-inhvkixy5564059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0354030438.USD","LU0868494617.USD","LU1066051225.USD","LU1551013425.SGD","BK4187","BK4543","BK4588","LU0149725797.USD","LU0820562030.AUD","LU2168564065.EUR","LU0689472784.USD","LU1093756325.SGD","LU1261432733.SGD","LU2756315664.SGD","LU1066051498.USD","LU2543165471.USD","LU0820561818.USD","LU0943347566.SGD","LU2756315318.SGD","LU1066053197.SGD","LU1084165304.USD","LU1066051811.HKD","LU2168564222.USD","LU0354030511.USD","BK4566","LU0077335932.USD","LU0820561909.HKD","LU2168563687.JPY","LU2168564149.EUR","LU1366333091.USD","BK4206","LU0267386448.USD","LU1064131342.USD","LU1988902786.USD","LU0157215616.USD","GE","LU1093756168.USD","LU1551013342.USD","BK4501","BK4585","LU0640476718.USD","159891","LU2087625088.SGD","LU1280957306.USD","LU2264538146.SGD","LU1366192091.USD","LU0353189680.USD","LU1119994496.HKD","LU0353189763.USD","LU2168564495.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629209736","title":"美股医疗 REITs 融资遇冷：National Healthcare(NHP.US)折价完成 IPO，最终募资4.62亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629209736","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629209736?lang=zh_cn&edition=full","pubTime":"2026-04-22 14:35","pubTimestamp":1776839700,"startTime":"0","endTime":"0","summary":"智通财经APP注意到，房地产投资信托基金National Healthcare Properties Inc.的 IPO 定价低于其原定区间，最终筹集了4.62亿美元。声明显示，National Healthcare计划将募集资金用于多种用途，包括偿还其循环信贷额度中约1.86亿美元的借款，以及为未来的物业收购提供资金。根据招股文件，National Healthcare在2025年营收为3.423亿美元，净亏损为5770万美元；而上年同期营收为3.54亿美元，净亏损为1.903亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431811.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","159891","SPCX","NHP","CFA","XLV","IPOS","BK4581","BK4588","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629038202","title":"商汤医疗宣布完成超5亿融资：估值10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629038202","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629038202?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:49","pubTimestamp":1776768592,"startTime":"0","endTime":"0","summary":"商汤医疗今日宣布已于年初完成超5亿元战略融资，公司估值正式迈入10亿美元独角兽行列。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260421/6391239419004391145135102.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260421/6391239419004391145135102.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33367/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["BK1109","BK1613","00020","159891","BK1615","80020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629969700","title":"港股异动 | 微创机器人-B(02252)涨超3% 海外市场新增订单增速加快 公司深耕欧洲核心高端医疗重地","url":"https://stock-news.laohu8.com/highlight/detail?id=2629969700","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629969700?lang=zh_cn&edition=full","pubTime":"2026-04-21 14:31","pubTimestamp":1776753118,"startTime":"0","endTime":"0","summary":"微创机器人-B(02252)涨超3%，截至发稿，涨2.7%，报35.04港元，成交额1.48亿港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260421/20260421143343_71602.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260421/20260421143343_71602.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431191.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4585","BK1617","159891","02252","VXUS","BK4588","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629870631","title":"医渡科技(02158)盈利预喜：AI医疗迎来“成人礼”，千亿市值之路的底层逻辑已清晰","url":"https://stock-news.laohu8.com/highlight/detail?id=2629870631","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629870631?lang=zh_cn&edition=full","pubTime":"2026-04-21 10:51","pubTimestamp":1776739874,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月20日，医渡科技一则盈利预喜公告，为整个AI医疗赛道注入了一剂强心针。2026财年上半年，公司经调整EBITDA已达5400万元，同比翻倍，亏损同比收窄72%，盈利拐点比预期提前一年到来。中国AI医疗的“成人礼”医渡科技的这份盈喜，不应被简单解读为一份漂亮的财务成绩单。在万级疾病管理市场、千亿医疗AI赛道、以及支付改革红利的共同驱动下，这家刚刚实现盈利的公司，正站在千亿市值之路的起点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1617","159891","AIPO","AGIX","02158","BK1518","ARTY","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628728471","title":"阿波罗全球管理(APO)拟12.5亿美元收购麦克森(MCK)医疗外科解决方案部门约13%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2628728471","media":"金吾财讯","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628728471?lang=zh_cn&edition=full","pubTime":"2026-04-20 20:26","pubTimestamp":1776687977,"startTime":"0","endTime":"0","summary":"金吾财讯 | 阿波罗全球管理（APO）旗下关联基金将收购麦克森(MCK)旗下医疗外科解决方案部门约 13% 的股权。该基金将向该部门投资 12.5 亿美元，以认购其可转换优先股的方式完成出资。本次交易对医疗外科解决方案部门的估值约为 130 亿美元。麦克森首席执行官布莱恩・泰勒表示，此次交易是公司规划分拆医疗外科解决方案部门进程中的重要里程碑。盘前交易数据显示，周一阿波罗全球管理股价下跌 1.25%，报 123.05 美元；麦克森股价亦跌 0.3062%，报 861.00 美元。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/YjZmMjQ4YmQ4ZjZmMDRlNTI1MzFkZTUxNzM2MjM3NjU3NDA0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YjZmMjQ4YmQ4ZjZmMDRlNTI1MzFkZTUxNzM2MjM3NjU3NDA0.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299445","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1323610961.USD","LU1023059063.AUD","BK4175","BK4533","BK4588","LU0965509283.SGD","LU0868494708.USD","LU1430594728.SGD","LU1506573853.SGD","LU1934455194.USD","APO","LU2112291526.USD","LU0965509101.SGD","LU1037948541.HKD","LU0314106906.USD","LU0122379950.USD","LU0251142724.SGD","LU0203347892.USD","LU1668664300.SGD","BK4184","LU2468319806.SGD","BK4585","LU0965509010.AUD","IE00B3S45H60.SGD","LU1366192091.USD","LU2089984988.USD","159891","LU2324357040.USD","LU1814569148.SGD","IE00B19Z3581.USD","LU0006061336.USD","LU1037948897.HKD","LU1061106388.HKD","LU1585245621.USD","LU0203345920.USD","LU0106831901.USD","LU0861579265.USD","IE00B775SV38.USD","BK4135","LU1934455863.HKD","LU1983260115.SGD","LU0683600562.USD","LU0787776722.HKD","LU0689626769.HKD","LU0048573561.USD","MCK","LU1791807156.HKD","LU1934455277.USD","LU0868494617.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628748283","title":"4月20日康辰药业跌5.59%，汇添富医疗积极成长一年持有混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628748283","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628748283?lang=zh_cn&edition=full","pubTime":"2026-04-20 16:16","pubTimestamp":1776672975,"startTime":"0","endTime":"0","summary":"证券之星消息，4月20日康辰药业跌5.59%，收盘报36.45元，换手率3.21%，成交量5.08万手，成交额1.88亿元。重仓康辰药业的前十大公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共10家，其中持有数量最多的公募基金为汇添富基金的汇添富医疗积极成长一年持有混合A。汇添富医疗积极成长一年持有混合A目前规模为17.45亿元，最新净值0.7403，较上一交易日下跌1.76%，近一年上涨27.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000021274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159891","603590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628316710","title":"艾柯医疗科创板IPO已问询 专注于神经介入创新医疗器械领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2628316710","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628316710?lang=zh_cn&edition=full","pubTime":"2026-04-20 15:35","pubTimestamp":1776670547,"startTime":"0","endTime":"0","summary":"据招股书，公司是一家处于商业化阶段、专注于神经介入创新医疗器械领域的集研发、生产及商业化为一体的国家级高新技术企业，并荣获国家级专精特新“小巨人”认定。截至招股说明书签署日，公司已有包括创新医疗器械产品Lattice血流导向密网支架、Grism远端闭合颅内取栓支架、Attractor颅内血栓抽吸导管等在内的十款神经介入治疗及通路类第三类医疗器械于中国获批，并有产品陆续于美国、东南亚等海外市场获批或提交注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430605.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","159883","09997","BK1222","09996","BK1574","BK1100","BK1583","159982","SPCX","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628719042","title":"北京微仙医疗：因隔离控制不严致混装风险，召回部分颅内支架系统","url":"https://stock-news.laohu8.com/highlight/detail?id=2628719042","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628719042?lang=zh_cn&edition=full","pubTime":"2026-04-20 13:40","pubTimestamp":1776663641,"startTime":"0","endTime":"0","summary":"蓝鲸新闻4月20日讯，北京市药品监督管理局网站近日通报，北京微仙医疗科技有限公司对其生产的颅内支架系统（国械注进20213130513）实施二级主动召回。经查，因生产过程中批次隔离控制不严，导致四个批次产品存在混装风险，可能造成标签规格与实际产品不符，进而影响植入时的展开性能。企业已收到两起相关投诉，但尚未报告患者伤害事件。目前，该公司已启动召回程序，要求相关单位停止使用并退回问题批次产品。消费者如发现所用产品涉及通报批次，应立即联系医疗机构或生产企业。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1776662633903745881","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628716658","title":"20位巴西顶尖医院院长访华 中国高端医疗赋能拉美医疗升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2628716658","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628716658?lang=zh_cn&edition=full","pubTime":"2026-04-20 12:13","pubTimestamp":1776658380,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者闫硕近些年，中国医药企业“走出去”已从企业自发行为升级为国家战略级趋势。在全球医疗格局重构的背景下，拉美市场凭借庞大的人口基数与旺盛的医疗升级需求，成为中国医疗企业布局海外的重要阵地。其中，巴西作为拉美医疗产业的龙头，凭借成熟的公私双轨医疗体系与强劲的区域辐射力，成为中国医疗出海拉美的战略支点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://biz.eastmoney.com/a/202604203710398946.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://biz.eastmoney.com/a/202604203710398946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159891","159100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628197947","title":"国盛证券：宠物医疗行业连锁化扩张 精品专科医院谋增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2628197947","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628197947?lang=zh_cn&edition=full","pubTime":"2026-04-20 11:45","pubTimestamp":1776656721,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国盛证券发布研报称，我国宠物医疗行业起步比美国晚20年，目前正处于连锁化扩张的关键阶段。该行认为，看历史经验，未来我国可以走出一条大连锁稳健发展、专科精品医院谋增长的道路。2)Banfield：以预防医学为主的连锁精品社区医院，与PetSmart深度绑定，在美国和波多黎各拥有超过1000家医院。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159891","BK0276","BK0052","002670"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628719049","title":"招银国际：医疗板块风险偏好有温和的修复 推荐翰森制药(03692)等6股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628719049","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628719049?lang=zh_cn&edition=full","pubTime":"2026-04-20 11:36","pubTimestamp":1776656176,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，MSCI中国医疗指数2026年初至今累计上涨12.3%，跑赢MSCI中国指数13.6%。近期在中国政府工作报告将生物医学列为新兴支柱产业的政策催化下，板块风险偏好有温和的修复。同时，AI制药技术突破与中国创新药出海 BD 的爆发形成双重共振，该行预期产业基本面加速向好。招商国际给予该6只股份“买入”的投资评级，目标价分别为46.41港元、113.86港元、34.87港元、10.34港元、82港元及35.46美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1969619763.USD","LU2242644610.SGD","LU2097828474.EUR","LU0502904849.HKD","159891","LU2097828714.EUR","03692","02268","LU2328871848.SGD","01801","01167","LU2488822045.USD","LU2097828631.EUR","BK1161","LU2097828557.USD","HK0000165453.HKD","01530","LU2097828805.USD","BK1191","BK1141","SG9999014674.SGD","BK1583","BK1589","BK1593","LU0455707207.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777043799395,"stockEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.0264},{"period":"3month","weight":-0.0932},{"period":"6month","weight":-0.0815},{"period":"1year","weight":0.0313},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0546},{"period":"3month","weight":-0.0104},{"period":"6month","weight":0.0362},{"period":"1year","weight":0.2418},{"period":"ytd","weight":0.0313}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医疗(159891)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医疗(159891)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医疗,159891,医疗股票,医疗股票老虎,医疗股票老虎国际,医疗行情,医疗股票行情,医疗股价,医疗股市,医疗股票价格,医疗股票交易,医疗股票购买,医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医疗(159891)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医疗(159891)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}